Artiva Biotherapeutics Inc (ARTV)
11.96
+0.74
(+6.60%)
USD |
NASDAQ |
Nov 05, 16:00
11.96
0.00 (0.00%)
After-Hours: 20:00
Artiva Biotherapeutics Shareholders Equity (Quarterly): -174.67M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -174.67M |
| March 31, 2022 | -99.41M |
| December 31, 2021 | -88.86M |
| Date | Value |
|---|---|
| September 30, 2021 | -79.20M |
| December 31, 2020 | -21.57M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-174.67M
Minimum
Mar 2024
-21.57M
Maximum
Dec 2020
-92.74M
Average
-88.86M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.16M |
| Total Liabilities (Quarterly) | 264.83M |
| Current Ratio | 6.355 |